National Cancer Institute I-Corps Overview

  • Investor Type
  • Accelerator/​Incubator

  • Status
  • Active

  • Investments
  • 14

  • Portfolio
  • 10

  • Exits
  • 2

Exits

National Cancer Institute I-Corps General Information

Company Description

National Cancer Institute I-Corps is an accelerator based in Rockville, Maryland. The firm offers a 8-week program that provides training to startups from biotech sector experts.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Accelerator/Incubator
Corporate Office
  • Rockville, MD 20850
  • United States
+1 (240)

National Cancer Institute I-Corps Investments (14)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Tinkeso Therapeutics 01-Apr-2024 Accelerator/Incubator Drug Discovery Generating Revenue
Duo Oncology 21-Mar-2024 Drug Discovery Pre-Clinical Trials
Center M 01-Jan-2024 Clinics/Outpatient Services Generating Revenue
Brain Thrive Technology 01-Jan-2023 Outcome Management (Healthcare) Startup
SimBioSys 18-Nov-2022 Decision/Risk Analysis Generating Revenue
SonALAsense 01-Jun-2022 Drug Delivery Clinical Trials - Phase 2
Kuda Therapeutics 01-Jan-2022 Drug Discovery Generating Revenue
Arvetas Biosciences 01-Jan-2021 Other Healthcare Technology Systems Startup
Kuda Therapeutics 01-Jan-2019 Grant Drug Discovery Generating Revenue
NanoMedTrix 23-Dec-2018 Accelerator/Incubator Diagnostic Equipment Generating Revenue
You’re viewing 10 of 14 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

National Cancer Institute I-Corps Exits (2)

Company Name Exit Date Exit Type Exit Size
Clara Biotech 30-Oct-2023 Merger/Acquisition
SonoVol 07-Feb-2022
To view National Cancer Institute I-Corps’s complete exits history, request access »

National Cancer Institute I-Corps Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

National Cancer Institute I-Corps FAQs

  • What is National Cancer Institute I-Corps?

    National Cancer Institute I-Corps is an accelerator based in Rockville, Maryland.

  • Where is National Cancer Institute I-Corps headquartered?

    National Cancer Institute I-Corps is headquartered in Rockville, MD.

  • How many investments has National Cancer Institute I-Corps made?

    National Cancer Institute I-Corps has made 14 investments.

  • What has National Cancer Institute I-Corps invested in?

    National Cancer Institute I-Corps has made numerous investments in companies like Tinkeso Therapeutics, Duo Oncology, and Center M within the Drug Discovery and Clinics/Outpatient Services industries.

  • What has National Cancer Institute I-Corps invested in recently?

    National Cancer Institute I-Corps's latest investment was on 01-Apr-2024 in Tinkeso Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process